1. Home
  2. ARMP vs BAFN Comparison

ARMP vs BAFN Comparison

Compare ARMP & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.38

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

HOLD

Current Price

$8.75

Market Cap

175.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
BAFN
Founded
N/A
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
175.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
ARMP
BAFN
Price
$5.38
$8.75
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
82.8K
47.5K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
1.00%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$4.26
52 Week High
$14.98
$11.34

Technical Indicators

Market Signals
Indicator
ARMP
BAFN
Relative Strength Index (RSI) 48.40 66.69
Support Level $5.12 $5.93
Resistance Level $5.63 $8.17
Average True Range (ATR) 0.44 0.65
MACD 0.03 0.06
Stochastic Oscillator 48.63 100.00

Price Performance

Historical Comparison
ARMP
BAFN

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company that operates through its wholly owned subsidiary. The Company generates the majority of its revenue from interest on loans and noninterest income. The primary sources of funding for its loans are loan payments, deposits, and borrowings. It is dependent on noninterest income, which is derived from net gain on the sales of the guaranteed portion of government-guaranteed loans and service fee income. The company provides personal banking and business banking services.

Share on Social Networks: